Gene study in stress-therapy for brain tumor patients
Part of Brain & nervous system, Cancer clinical trials.
This trial studies how a stress therapy might affect gene activity in people with glioma (a type of brain tumor). It mainly looks to see if this kind of treatment is safe and suitable for eligible participants.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old and have glioma (a brain tumor)
- You are willing to receive the study treatment and sign consent forms
- You do not have an active infection or a weakened immune system
- You do not have other serious infections in the brain or central nervous system
- You do not have cancer outside the nervous system
- You do not have severe psychiatric illness or uncontrolled diabetes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether psychological stress is linked to how a diffuse astrocytoma grows and changes into a more aggressive secondary brain tumor. It may help doctors better understand stress-related factors during standard treatment, and how to monitor patients more closely.
This study looks for connections between detailed brain scans and tumor genetic features in people with glioblastoma. It may help researchers find better ways to understand your tumor and tailor future care.
This trial tests a new gene therapy given directly into the brain tumor. It's for people with high-grade glioma, either newly diagnosed or after one recurrence, to see if it can help control the tumor.
This study looks at whether psychological stress is linked to how newly diagnosed oligodendroglioma progresses into a more aggressive brain tumor. You may help researchers understand stress patterns during standard chemo-radiation treatment.
This trial tests a two-part treatment: an injected virus (DB107-RRV) plus an oral medication (DB107-FC) for people whose high-grade glioma (a type of brain tumor) has come back. The virus is designed to deliver a gene that makes the tumor sensitive to the oral drug, which then helps kill the cancer cells.
This trial uses a special MRI scan to study the genetics of gliomas (a type of brain tumor). It may help doctors better understand your tumor and choose the right treatment. You can join if you have a suspected or confirmed low- or high-grade glioma that still has a measurable tumor after surgery.
Hear when a new Genetic Change trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.